Delivery Order SPE2DB22D2206-SPE2DB25FHV69

Award Date 7/10/25
Potential Completion Date 7/31/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRUQAP 200 MG TABLET 64S, a pharmaceutical product, with a ceiling value of $15,514.40 and a completion date of July 16, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,514.40 firm-fixed-price contract is for the delivery of TRUQAP 200 MG TABLET 64S, a medical supply product, with a completion date of July 14, 2025. The award is not associated with a set-aside program and is part of AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRUQAP 200 MG TABLET 64S, a pharmaceutical product, with an ultimate completion date of July 28, 2025 and a ceiling value of $15,514.40. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRUQAP 200 MG TABLET 64S, with a firm fixed price of $15,514.40 and a period of performance through July 30, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRUQAP 200 MG TABLET 64S, a pharmaceutical product, with a firm fixed price of $15,514.40 and a completion date of July 8, 2025. The contract is not set aside and is a delivery order, indicating it is part of a larger indefinite delivery contract (IDC) vehicle. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRUQAP 200 MG TABLET 64S, a medical supply product, with a ceiling value of $31,028.80. The contract is a firm fixed price, non-set-aside award with a performance period ending on July 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,514.40, is for the delivery of TRUQAP 200 MG TABLET 64S medical products. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 9, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of TRUQAP 200 MG TABLET 64S, a pharmaceutical product, with a ceiling value of $31,028.80 and a performance period through January 24, 2025. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,514.40, is for the delivery of TRUQAP 200 MG TABLET 64S, a pharmaceutical product. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,514.40, is for the delivery of TRUQAP 200 MG TABLET 64S medical supplies. It is a firm fixed-price delivery order contract with a period of performance through March 31, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHV69
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRUQAP 200 MG TABLET 64S, with an ultimate completion date of July 31, 2025 and a ceiling value of $15,514.40.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and designated as SPE2DX. This prime contract provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization registered in SAM.gov since 2002 and serves as a critical supplier of medical and pharmaceutical products to federal agencies.

Generated 10/12/25, 12:45 AM